DAX1 Overexpression in Pediatric Adrenocortical Tumors: A Synergic Role with SF1 in Tumorigenesis

Abstract DAX1 transcription factor is a key determinant of adrenogonadal development, acting as a repressor of SF1 targets in steroidogenesis. It was recently demonstrated that DAX1 regulates pluripotency and differentiation in murine embryonic stem cells. In this study, we investigated DAX1 expression in adrenocortical tumors (ACTs) and correlated it with SF1 expression and clinical parameters. DAX1 and SF1 protein expression were assessed in 104 ACTs from 34 children (25 clinically benign and 9 malignant) and 70 adults (40 adenomas and 30 carcinomas). DAX1 gene expression was studied in 49 ACTs by quantitative real-time PCR. A strong DAX1 protein expression was demonstrated in 74% (25 out of 34) and 24% (17 out of 70) of pediatric and adult ACTs, respectively (χ2=10.1, p=0.002). In the pediatric group, ACTs with a strong DAX1 expression were diagnosed at earlier ages than ACTs with weak expression [median 1.2 (range, 0.5–4.5) vs. 2.2 (0.9–9.4), p=0.038]. DAX1 expression was not associated with functional status in ACTs. Interestingly, a positive correlation was observed between DAX1 and SF1 protein expression in both pediatric and adult ACTs (r=0.55 for each group separately; p<0.0001). In addition, DAX1 gene expression was significantly correlated with SF1 gene expression (p<0.0001, r=0.54). In conclusion, DAX1 strong protein expression was more frequent in pediatric than in adult ACTs. Additionally, DAX1 and SF1 expression positively correlated in ACTs, suggesting that these transcription factors might cooperate in adrenocortical tumorigenesis.

[1]  E. Lalli.  Methodological pitfalls in the study of DAX-1 function , 2014, Cell Death and Disease.

[2]  M. Almeida,et al.  Differences in the molecular mechanisms of adrenocortical tumorigenesis between children and adults , 2012, Molecular and Cellular Endocrinology.

[3]  F. Beuschlein,et al.  High diagnostic and prognostic value of steroidogenic factor-1 expression in adrenal tumors. , 2010, The Journal of clinical endocrinology and metabolism.

[4]  A. Latronico,et al.  Steroidogenic factor 1 overexpression and gene amplification are more frequent in adrenocortical tumors from children than from adults. , 2010, The Journal of clinical endocrinology and metabolism.

[5]  E. Lalli,et al.  Targeting DAX-1 in embryonic stem cells and cancer , 2010, Expert opinion on therapeutic targets.

[6]  S. Lessnick,et al.  EWS/FLI and its downstream target NR0B1 interact directly to modulate transcription and oncogenesis in Ewing's sarcoma. , 2009, Cancer research.

[7]  E. Morii,et al.  Tumorigenic role of orphan nuclear receptor NR0B1 in lung adenocarcinoma. , 2009, The American journal of pathology.

[8]  Pascal Barbry,et al.  Dax‐1 Knockdown in Mouse Embryonic Stem Cells Induces Loss of Pluripotency and Multilineage Differentiation , 2009, Stem cells.

[9]  F. Beuschlein,et al.  Limited prognostic value of the 2004 International Union Against Cancer staging classification for adrenocortical carcinoma , 2009, Cancer.

[10]  Paul G. Gauger,et al.  Molecular Classification and Prognostication of Adrenocortical Tumors by Transcriptome Profiling , 2009, Clinical Cancer Research.

[11]  E. Lalli,et al.  DAX1, a direct target of EWS/FLI1 oncoprotein, is a principal regulator of cell-cycle progression in Ewing's tumor cells , 2008, Oncogene.

[12]  C. Lotfi,et al.  Expression of insulin-like growth factor-II and its receptor in pediatric and adult adrenocortical tumors. , 2008, The Journal of clinical endocrinology and metabolism.

[13]  A. Latronico,et al.  The Molecular Pathogenesis of Childhood Adrenocortical Tumors , 2007, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

[14]  James M. Piret,et al.  Meta-Analysis of Differentiating Mouse Embryonic Stem Cell Gene Expression Kinetics Reveals Early Change of a Small Gene Set , 2006, PLoS Comput. Biol..

[15]  Elisabeth Brambilla,et al.  DNA repair by ERCC1 in non-small-cell lung cancer and cisplatin-based adjuvant chemotherapy. , 2006, The New England journal of medicine.

[16]  J. Gustafsson,et al.  DAX-1 expression is regulated during mammary epithelial cell differentiation. , 2006, Endocrinology.

[17]  K. Niakan,et al.  Novel role for the orphan nuclear receptor Dax1 in embryogenesis, different from steroidogenesis. , 2006, Molecular genetics and metabolism.

[18]  J. Bertherat,et al.  Mutations of beta-catenin in adrenocortical tumors: activation of the Wnt signaling pathway is a frequent event in both benign and malignant adrenocortical tumors. , 2005, Cancer research.

[19]  G. Arnaldi,et al.  0021-972X/05/$15.00/0 The Journal of Clinical Endocrinology & Metabolism 90(9):5446–5455 Printed in U.S.A. Copyright © 2005 by The Endocrine Society doi: 10.1210/jc.2005-0836 Expression Profiles for Steroidogenic Enzymes in Adrenocortical Disease , 2005 .

[20]  G. Hammer,et al.  Nuclear receptors Sf1 and Dax1 function cooperatively to mediate somatic cell differentiation during testis development , 2005, Development.

[21]  E. Lalli,et al.  Amplification of the steroidogenic factor 1 gene in childhood adrenocortical tumors. , 2005, The Journal of clinical endocrinology and metabolism.

[22]  L. Thompson,et al.  Adrenal Cortical Neoplasms in the Pediatric Population: A Clinicopathologic and Immunophenotypic Analysis of 83 Patients , 2003, The American journal of surgical pathology.

[23]  A. Swain,et al.  Dax-1 (dosage-sensitive sex reversal-adrenal hypoplasia congenita critical region on the X chromosome, gene 1) gene transcription is regulated by wnt4 in the female developing gonad. , 2003, Molecular endocrinology.

[24]  I. Saito,et al.  Expression profiles of COUP-TF, DAX-1, and SF-1 in the human adrenal gland and adrenocortical tumors: possible implications in steroidogenesis. , 2001, Molecular genetics and metabolism.

[25]  P. Hindmarsh,et al.  A mutation in the gene encoding steroidogenic factor-1 causes XY sex reversal and adrenal failure in humans , 1999, Nature Genetics.

[26]  F. Beuschlein,et al.  DAX-1 expression in human adrenocortical neoplasms: implications for steroidogenesis. , 1998, The Journal of clinical endocrinology and metabolism.

[27]  E. Lalli,et al.  DAX-1 blocks steroid production at multiple levels. , 1998, Endocrinology.

[28]  E. McCabe,et al.  DAX1 gene expression upregulated by steroidogenic factor 1 in an adrenocortical carcinoma cell line. , 1997, Biochemical and molecular medicine.

[29]  G. Chrousos,et al.  Extensive personal experience: adrenocortical tumors. , 1997, The Journal of clinical endocrinology and metabolism.

[30]  E. McCabe,et al.  Identification of a putative steroidogenic factor-1 response element in the DAX-1 promoter. , 1995, Biochemical and biophysical research communications.

[31]  A. Monaco,et al.  Mutations in the DAX-1 gene give rise to both X-linked adrenal hypoplasia congenita and hypogonadotropic hypogonadism , 1994, Nature.

[32]  A. Monaco,et al.  An unusual member of the nuclear hormone receptor superfamily responsible for X-linked adrenal hypoplasia congenita , 1994, Nature.